📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Anti-type I interferon antibodies as a cause of severe COVID-19. (2022)

First Author: Fajgenbaum DC

Attributed to: Characterisation and therapeutic manipulation of Flaviviridae innate immune evasion funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.12703/r-01-0000010

PubMed Identifier: 35812362

Publication URI: http://europepmc.org/abstract/MED/35812362

Type: Journal Article/Review

Volume: 11

Parent Publication: Faculty reviews

ISSN: 2732-432X